Histological investigations, in particular, have confirmed the expression of PSMA in the microvasculature of thyroid tumors, where PSMA expression was associated with malignant disease, poor prognostic markers, and a lower progression-free survival (PFS) [18]. Here, FOLH1 is linked to thyroid tumor.